TREVOR ROBEY INC
OpenClaw Research Intelligence

Citation-backed biomedical intelligence for enterprise decision-making

Autonomous multi-agent research engine that synthesizes pharmacovigilance signals, drug discovery data, and clinical trial landscapes from authoritative databases. Every claim maps to a verifiable identifier. No hallucinated references.

Request Sample Deliverable View Products

Research-grade data packs

Pharmacovigilance Signal Synthesis

135+
Verified citations per report

Adverse event signal detection, AEMS (formerly FAERS, daily updates since Aug 2025) disproportionality analysis, drug interaction profiling, and clinical action recommendations across compound cohorts.

OpenFDA AEMS, DailyMed, RxNorm, PubMed, OpenFDA

Drug Discovery Intelligence

200+
Verified citations per report

Compound profiling with ADMET properties, target-compound mapping, molecular interaction networks, and competitive landscape analysis.

PubChem, ChEMBL, RxNorm, UniProt, OpenTargets

Clinical Trial Landscape

180+
Verified citations per report

Global trial mapping, endpoint analysis, enrollment trends, competitor pipeline tracking, and regulatory milestone timelines.

ClinicalTrials.gov, PubMed, WHO ICTRP, EuropePMC

Target Validation Dossier

289+
Verified citations per report

Multi-omics target-disease association scoring, genetic evidence mapping, tissue expression profiling, and druggability assessment.

OpenTargets, UniProt, HPA, ChEMBL, RxNorm

How it works

01 — Scout

Systematic Database Scan

Autonomous scan of FDA registries, peer-reviewed literature, and pharmacological databases. Cross-reference normalization across identifier systems (PMID, NCT, RxNorm, PubChem CID, UniProt).

02 — Analyst

Quantitative Signal Analysis

Disproportionality metrics (ROR, PRR), drug interaction matrices, pharmacokinetic and pharmacodynamic profiling with molecular-level specificity.

03 — Synthesizer

Cross-Validated Synthesis

Signal hierarchy integrating scout and analyst outputs. Contradiction resolution, confidence tier assignment, and actionable clinical or strategic recommendations.

04 — Quality Audit

Citation Verification

Automated enforcement of citation density thresholds. Cross-reference validation, append-only evidence ledger with SHA-256 chain-hashed integrity, provenance tracking.

Sample: Pharmacovigilance Signal Synthesis

41
Verified Citations
7
Identifier Types
48
Pages
3
Agent Sections

Sample Citation Index

Type Identifier Context
PMID 30232222 ICI myocarditis systematic review, JACC 2018
NCT NCT00302159 Valproic acid + temozolomide in GBM
RxNorm 1597876 Nivolumab (Opdivo) pharmacology
DOI 10.1056/NEJMoa1716078 NEJM: ICI cardiac adverse events
UniProt P11712 CYP2C9 enzyme — VPA/TMZ interaction

Every identifier above resolves in its source database. Check PMID:30232222 at pubmed.ncbi.nlm.nih.gov — it resolves to Wang et al., JACC 2018.

Request Full Sample

Pricing

Research Intelligence Pack

$2,500 – $4,950
per report
  • Single-topic research report (48+ pages)
  • 200+ verified citations across all identifier types
  • Citation index CSV with provenance
  • Methodology statement
  • 72-hour delivery via secure email
Request a Pack

Custom Intelligence Mission

$15,000 – $35,000
per project
  • Choose any pharmacovigilance, drug discovery, or competitive intelligence topic
  • Full multi-section research report (40–80+ pages)
  • Citation index CSV with full provenance chain
  • Methodology statement and schema definition
  • Evidence appendix with chain-hashed integrity
  • Delivery via Snowflake, AWS Data Exchange, or BigQuery
Initiate Mission